ACUTE POST COMPLICATIONS IN STROKE PATIENTS VISITING A TERTIARY TEACHING HOSPITAL by T., Spurthi et al.
 
Original Article 
ACUTE POST COMPLICATIONS IN STROKE PATIENTS VISITING A TERTIARY TEACHING 
HOSPITAL 
 
SPURTHI T.1*, REKHA RANI K.2, NAVYA Y.3, SWATHI D.4, RAMESH KUMAR P.4 
*1Department of Pharmacy Practice, Creative Educational Society’s College of Pharmacy, N. H.7, Chinnatekur, Kurnool, Andhra Pradesh, 
2,3Department of Pharmaceutics, Creative Educational Society’s College of Pharmacy, N. H.7, Chinnatekur, Kurnool, Andhra Pradesh, 4Pharm. D 
Student, Department of Pharmacy Practice, Creative Educational Society’s College of Pharmacy, N. H.7, Chinnatekur, Kurnool, Andhra Pradesh 
Email: t.spurthireddy@gmail.com  
Received: 22 Oct 2017 Revised and Accepted: 08 Mar 2018 
ABSTRACT 
Objective: The study was focused on assessing the incidence of stroke and their association with types of the risk factor, with an emphasis on acute 
post complications and their symptomatic management for early detection. 
Methods: A prospective observational study was carried out on stroke patients visiting a medicine department of a tertiary hospital, Andhra 
Pradesh, India from August 2017 to November 2017. Patient’s demographics and lab data was collected for analysis. 
Results: A total of 110 patients participated in the study. Among them high incidence is males (69%), 61-80yrs (48%), with 2 risk factors (35%) 
among which age (67%) and hypertension (66%) were related to the high degree of prevalence. 47% of the study population were identified with 
one complication, among which seizures account for 38% of patients. All the complications associated with the condition were treated with drug 
classes, in which anti-epileptic drugs (AEDs) were the mainstay in the management of epilepsy. 
Conclusion: Brain edema and seizure attack were the most accountable complications identified in the study population. The early detection of 
these problems can improve the stroke outcomes and can reduce the mortality or disability rate.  
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Apoplexy, the word used by Hippocrates, who is considered as the 
father of medicine now commonly known as a stroke, which is 
defined as a syndrome with several pathophysiologies involved. 
According to the World Health Organization (WHO) it is a condition 
“characterized by rapidly developing clinical symptoms and/or signs 
of focal, and at times global, loss of cerebral function, with symptoms 
lasting more than 24 h leading to death with no apparent cause 
other than that of vascular origin” [1].  
Globally cardiovascular diseases are considered to be the first 
commonest cause of mortality among which stroke occupies the 
second place [2]. As per India stroke Factsheet updated in 2012, the 
age-adjusted estimates prevalence rate ranges between 84/100,000 
and 262/100,000 in rural and between 334/100,000 and 
424/100,000 in urban areas [3]. Reports show a decline in death 
rates in past decades still it holds approximately 20%, ranging from 
15% to 58% depending on stroke subtype. Based on risk factors and 
pathophysiological changes, stroke is mainly classified as Ischemic 
and hemorrhagic type. Both share a crucial role in the extent and site 
of brain damage that determines the pre and post-stroke 
complications, therapeutic interventions and socioeconomic burden 
on patients. In addition to the initial neuronal damage resulting in 
functional, cognitive, and sensory deficits associated with the 
disease, patients are also at high risk of developing a wide range of 
medical complications, which account for 40% to 96% [4], involving 
both short-term and long-term complications: pneumonia, urinary 
tract infection (UTI), pressure ulcer, falls, venous thromboembolism, 
seizures, osteoporosis and central pain states [1].  
Recent studies showed an incidence rate of 119-145/100,000 in 
India [3]. High chance of recurrence in stroke survivors, post-stroke 
complication risk and long-term rehabilitation due to disease-
associated disability and economic burden on patient demands for 
its early identification. So the objective of this study is to focus on 
the incidence of these complications whose identification helps in 
early recognition, prevention and management of the condition and 
improving the patient care. 
MATERIALS AND METHODS 
A prospective observational study for assessing the demographic 
parameters, risk factors associated and post-complication of stroke 
patients was conducted in the medicine department of a tertiary 
care teaching hospital for a period of 6 mo from August 2017 to 
November 2017 in Kurnool district, Andhra Pradesh.  
Materials 
Consent form for patients, Data entry form 1 for demographic details 
and Data entry form 2 for listing the post-stroke complications with 
respective treatment chart. 
Inclusion criteria 
The patients who meet the following criteria was enrolled where, 
Inclusion criteria were patients aged ≥ 18 y of both genders, who 
had provided a consent to participate in the study.  
Exclusion criteria 
Patients with diseases like psychiatry, cancer, pregnant and nursing 
mothers were excluded.  
Study method 
The details of cases found in the medicine department, including 
patient name, age, sex, past medical history and other relevant 
information were collected. The collected prescription was entered 
into the Microsoft Office Excel sheet according to their age, gender; 
therapeutic category and mean percentage were calculated. 
Ethical approval 
Consent from all the patients was taken in respective form and Ethical 
approval was taken with a no.9 from Viswabharathi Medical College. 
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Fig. 1: Percentage of the study population diagnosed with 
ischemic and hemorrhagic stroke 
 
RESULTS 
A total of 110 patients who are diagnosed with any one type of 
stroke are recruited for the study after a proper consent was taken. 
Out of them, the highest incidence is ischemic stroke affecting 102 
(93%) patients followed by 8 (7%) patients with hemorrhagic type 
represented in Error! Reference source not found.. Among Ischemic 
stroke patients, most of them are males 70 (69%) compared to 
females 32 (31%) as shown in Error! Reference source not found.. It 
was found that all the hemorrhagic patients are found to be males. 
 
 
Fig. 2: Gender distribution among patients suffering from 
ischemic stroke 
 
The patients based on their demographic data were categorized into 
different age groups and among them, most of the patients were 
identified under 61-80 y range i.e., 53(48%). Age groups and 
patients distributed among are mentioned in Error! Reference 
source not found. 
 
Table 1: Age distribution in stroke patients 
Age range Sum (n=110) % 
0-20 0 0 
21-40 8 7 
41-60 45 41 
61-80 53 48 
81-100 4 4 
 
In the study population nearly 35% of them were found with 2 risk 
factors, followed by 25% by 3 and 14%>3 risk issues associated. 
Only 5% of them showed nil risk factors, as depicted in Error! 
Reference source not found. Among them, age (67%) and 
hypertension (66%) was related to the high degree of prevalence 
and other risks in patients are shown in Table 2. 
 
Table 2: Number of risk factors 
Risk factor Patient number Percentage 
0 6 5% 
1 23 21% 
2 39 35% 
3 27 25% 
>3 15 14% 
 
The patients are treated with the different class of drugs among which 
anti-platelets 88 (91.16%) accounts the highest percentage and nitrates 
6 (0.62%) is the least prescribed. The remaining classes of drugs and 
their percentage of usage are mentioned in following table 3. 
 
Table 2: Type of risk and patient percentage 
Risk factor Patient number Percentage 
Age 74 67% 
Alcohol 24 22% 
Cigarette smoking 13 12% 
Diabetes mellitus 40 36% 
Hypertension 73 66% 
Cardiac disease 12 11% 
Parkinson’s disease 2 2% 
 
It was noted that 47% of the study population were identified 
with one complication, among which seizures account for 38% of 
patients. 45% of patients developed brain edema, confirmed by 
CT scans within 2-5 d of their disease onset. The individual 
percentages of patients with the complications are mentioned in 
Table 3 and Table 4. 
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Table 3: Patients with stroke complication 
Number of complication Patient number Percentage 
0 14 13% 
1 52 47% 
2 36 33% 
3 6 5% 
>3 2 2% 
 
Table 4: Type of complication and their percentage 
Complication type Patient number Percentage 
Brain edema 50 45.5 
Seizures 35 31.8 
DVT 26 23.6 
Depression and anxiety 12 10.9 
Limb pain 9 8.2 
Urinary tract infection 4 3.6 
Chest infections 4 3.6 
 
All the complications associated with the condition were treated 
with drug classes in the study population. Edema, due to the 
pathophysiological changes of ischemia was controlled by using an 
osmotic diuretic (mannitol) in all 50 patients (100%). In all age 
groups, anti-epileptic drugs (AEDs) were the mainstay in the 
management of epilepsy. AEDs accounted for nearly 75% of post-
stroke seizure therapy, followed by benzodiazepines i.e., clonazepam 
(25%). The different complications and their respective 
management options, by utilizing the varied class of drugs are listed 
in the following Table 5 and AEDs= Anti-Epileptic drugs; BZDs= 
Benzodiazepines; CTX=Ceftriaxine; MEM=Meropenam; 
NSAIDs=Non-steroidal anti-inflammatory drugs; OXA=Ofloxacin; 




Table 5: Drug utilization in the therapy of post-stroke complications 
Complication  Class of drugs used  No of patients Percentage 
Seizures BZDs 9 25 
AEDs 27 75 
Limb pain NSAIDS 16 61.5 
Tramadol 5 19.2 
Muscle Relaxants 5 19.2 
DVT LMWHs 24 82.8 
Others  5 17.2 
Depression and anxiety BZD 8 61.5 
SSRIs 4 30.8 
TCAs 1 7.7 
UTI Fluoroquinolones (OXA) 4 100 
Chest infections Carbepenems (MEM) 2 40 
Fluroquinolones (MXF) 2 40 
Cephalosporins (CTX) 1 20 
AEDs= Anti-Epileptic drugs; BZDs= Benzodiazepines; CTX=Ceftriaxine; MEM=Meropenam; NSAIDs=Non-steroidal anti-inflammatory drugs; 
OXA=Ofloxacin; SSRIs=Seratonin selective re-uptake inhibitors; TCAs=Tricyclic anti-depressants. 
 
 
Fig. 3: Highly prescribed drug class in various post-stroke complications 
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DISCUSSION 
Many studies on the incidence of stroke reported the 
predominance of the ischemic type over hemorrhagic, in 
concordance with our study results were 93% of the patients 
belong to that group [5-7].  
The demographic parameters of the study populations show a 
dominance of male gender (71%), of age group 61-80 y range i.e., 
(48%). Similar reports were shown in other Studies [5-8]. 
In the study population, nearly 35% of them were found with 2 risk 
factors, similar to another study by Shrestha [7]. A study by Vaidya 
detailed that hypertension is one of the most common risk factors 
associated with stroke patients, in similarity with our results, 
showing 66% of the population with hypertension [5]. A 
retrospective study by another author also reported that 62% of 
their stroke patients had hypertension as the risk factor [9].  
Various medical, neurological and psychological complications are 
allied to stroke after the acute attack. The identification of such 
complications in the first days of effect helps to notice the early 
preventability with a high degree of functional outcome. In our 
study, high incidence of patients was with one complication i.e., 
47%, in similarity with Karen c. Johnston [10,1]. A population-based 
study in Sweden found that patients over 60 y of age, 45% of 
seizures were secondary to stroke and associated with a 23–35-fold 
increase in the incidence of seizure. In our study, most of the 
patients showed seizure symptom during a stroke attack. In earlier 
studies, a highly variable, ranging from a low of 7.7% to a high of 
42.8% in the incidence of seizures were noted, but the recent study 
series shows fewer variants with average 10% risk of seizures 
within 9-10 y after stroke [11]. All the other complications were 
treated as per their standard guidelines for symptomatic relief. 
CONCLUSION 
Thus the correct identification of the risk factors associated with the 
stroke patients prior; help us to bring down the cost burden along 
with improvement in the quality of life effectively. This study turned 
out to be similar to many other studies in different countries 
implementing the need for patient-specific risk correction by using 
standard therapeutic guidelines, for effective patient-centred care. 
This study is mainly limited to less number of sample in a single 
center, hence further research in assessing the risk factors and post 
complications in stroke patients, paving for a significant disease 
management outcomes. 
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